The use of prophylactic eye drops during high-dose cytosine arabinoside therapy.
Gococo
K O
KO
Lazarus
H M
HM
Lass
J H
JH
D000287:Administration, Topical; D003561:Cytarabine / Q000009:adverse effects*; D003841:Deoxycytidine / Q000008:administration & dosage*; D004311:Double-Blind Method; D006801:Humans; D007637:Keratoconjunctivitis / Q000139:chemically induced / Q000517:prevention & control*; D009883:Ophthalmic Solutions; D011239:Prednisolone / Q000008:administration & dosage*; D011446:Prospective Studies
D009883:Ophthalmic Solutions; D003561:Cytarabine; D003841:Deoxycytidine; D011239:Prednisolone